CCL18 and breast cancer: CCL-18 is a key factor secreted by TAMs to induce cancer cell epithelial-mesenchymal transition (EMT), enhance breast cancer metastasis, and reduce patient survival (Chen et al., 2011; Su et al., 2014; Nie et al., 2017).